Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcranial Photobiomodulation for Reducing Autism Symptoms in Children.

NCT06359080 is registered in ClinicalTrials.gov with JelikaLite LLC as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06359080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcranial Photobiomodulation for Reducing Autism Symptoms in Children.
Lead sponsor
JelikaLite LLC
Phase
Not applicable
Overall status
Completed
Start date
May 8, 2022
Completion date
December 11, 2022
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.